| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.067 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |